BGI Genomics Co., Ltd. (SHE:300676)
China flag China · Delayed Price · Currency is CNY
47.76
+0.88 (1.88%)
Apr 29, 2025, 2:45 PM CST

BGI Genomics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
3,6933,8424,3337,0366,7548,387
Upgrade
Other Revenue
24.624.616.9116.6711.7510.31
Upgrade
Revenue
3,7183,8674,3507,0536,7668,397
Upgrade
Revenue Growth (YoY)
-11.82%-11.10%-38.33%4.24%-19.42%199.86%
Upgrade
Cost of Revenue
2,3262,3642,2023,5282,8453,382
Upgrade
Gross Profit
1,3921,5032,1473,5263,9215,015
Upgrade
Selling, General & Admin
1,3921,4241,4411,9981,6371,630
Upgrade
Research & Development
612.34601.38523.23526.46474.79611.32
Upgrade
Other Operating Expenses
30.6916.774.1-8924.06-10.23
Upgrade
Operating Expenses
2,2452,2402,0352,6202,2412,372
Upgrade
Operating Income
-853.62-736.53112.94905.271,6802,643
Upgrade
Interest Expense
-37.16-52.02-91.56-100.76-104.72-89.04
Upgrade
Interest & Investment Income
119.46125.72153.33424.36218.16119.22
Upgrade
Currency Exchange Gain (Loss)
-19.09-19.09-11.36-2.27-39.76-138.51
Upgrade
Other Non Operating Income (Expenses)
8.39-3.41-35.86-91.43-4.04-35.45
Upgrade
EBT Excluding Unusual Items
-782.01-685.33127.491,1351,7502,499
Upgrade
Impairment of Goodwill
-10.64-10.64----
Upgrade
Gain (Loss) on Sale of Investments
-75.13-87.41-34.3680.7386.4152.2
Upgrade
Gain (Loss) on Sale of Assets
-3.62-0.632.760.11-3.88-4.23
Upgrade
Asset Writedown
-126.93-125.97-9.25-209.24-102.24-105.02
Upgrade
Other Unusual Items
26.8523.8628.890.0215.870
Upgrade
Pretax Income
-971.47-886.11115.541,0071,7462,442
Upgrade
Income Tax Expense
8.0825.9921.85197.51268.19340.24
Upgrade
Earnings From Continuing Operations
-979.55-912.193.68809.291,4782,102
Upgrade
Minority Interest in Earnings
11.769.41-0.78-6.52-16.16-11.77
Upgrade
Net Income
-967.79-902.6992.9802.771,4622,090
Upgrade
Preferred Dividends & Other Adjustments
-----1.4
Upgrade
Net Income to Common
-967.79-902.6992.9802.771,4622,089
Upgrade
Net Income Growth
---88.43%-45.07%-30.08%656.43%
Upgrade
Shares Outstanding (Basic)
413412410410410398
Upgrade
Shares Outstanding (Diluted)
413412412410412399
Upgrade
Shares Change (YoY)
2.89%0.01%0.48%-0.32%3.11%-0.20%
Upgrade
EPS (Basic)
-2.34-2.190.231.963.565.25
Upgrade
EPS (Diluted)
-2.34-2.190.231.963.555.24
Upgrade
EPS Growth
---88.48%-44.90%-32.25%658.65%
Upgrade
Free Cash Flow
-816.37-433.76-827.62-1,1362,0933,302
Upgrade
Free Cash Flow Per Share
-1.98-1.05-2.01-2.775.088.27
Upgrade
Dividend Per Share
--0.1001.0000.3500.350
Upgrade
Dividend Growth
---90.00%185.71%-250.00%
Upgrade
Gross Margin
37.43%38.87%49.37%49.99%57.95%59.72%
Upgrade
Operating Margin
-22.96%-19.05%2.60%12.83%24.83%31.48%
Upgrade
Profit Margin
-26.03%-23.34%2.14%11.38%21.60%24.88%
Upgrade
Free Cash Flow Margin
-21.96%-11.22%-19.03%-16.10%30.93%39.32%
Upgrade
EBITDA
-426.6-320.95482.761,2621,9592,945
Upgrade
EBITDA Margin
-11.47%-8.30%11.10%17.90%28.95%35.08%
Upgrade
D&A For EBITDA
427.01415.57369.81357.13278.78302.33
Upgrade
EBIT
-853.62-736.53112.94905.271,6802,643
Upgrade
EBIT Margin
-22.96%-19.05%2.60%12.83%24.83%31.48%
Upgrade
Effective Tax Rate
--18.92%19.62%15.36%13.93%
Upgrade
Revenue as Reported
3,7183,8674,3507,0536,766-
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.